Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Table 5 Analysis of factors associated with peripheral malaria by microscopy among delivering women

Variable	Peripheral malaria		Crude OR	P-value	Adjusted OR	P-value
	N	No. peripheral malaria positive (%)	(95% CI)		(95% CI)
Maternal age
<20 years	97	33 (34.02)	130 (0.80, 2.10)	0.291	1.28 (0.76, 2.14)	0.350
≥20 years	334	95 (28.44)	Reference		Reference
Health facility
Geita hospital	265	67 (25.28)	Reference		Reference
Katoro HC	166	61 (36.75)	1.72 (1.13, 2.61)	0.012	1.76 (1.12, 2.77)	0.014
Level of education
None/Primary	360	113 (31.39)	1.71 (0.93, 3.15)	0.086	1.29 (0.66, 2.53)	0.458
Secondary/Higher	71	15 (21.13)	Reference		Reference
Occupation
Peasant/livestock	370	116 (31.35)	1.86 (0.96, 3.64)	0.068	1.43 (0.69, 2.98)	0.340
Employed/business	61	12 (19.67)	Reference		Reference
SP receipt
<3 doses	405	124 (30.62)	Reference		Reference
≥3 doses	26	4 (15.38)	0.41 (0.14, 1.22)	0.110	0.68 (0.22, 2.14)	0.489
ANC visits
1-3	276	88 (31.88)	1.35 (0.87, 2.09)	0.186	1.32 (0.83, 2.12)	0.243
≥4	155	40 (25.81)	Reference		Reference
Bed net use
No	10	5 (50.00)	Reference		Reference
Yes	403	118 (29.28)	0.41 (0.12, 1.45)	0.169	0.39 (0.12, 1.39)	0.164

ANC = antenatal care; OR = odds ratio, 95% CI = 95% confidence interval, SP = sulphadoxine-pyrimethamine; Significant p-values are presented in bold.

ISSN: 1475-2875